3,194
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Tuberculosis treatment and resulting abnormal blood glucose: a scoping review of studies from 1981 - 2021

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2114146 | Received 20 Jun 2022, Accepted 11 Aug 2022, Published online: 30 Sep 2022

References

  • World Health Organisation. Tuberculosis Fact Sheet Geneva: WHO; 2021 [cited 2022 May 25]. Available from: http://www.who.int/news-room/fact-sheets/detail/tuberculosis.
  • International Diabetes Federation. Diabetic facts and figures Brussels, Belgium: IDF; 2021 [updated 09 December 2021; cited 2022 May 25]. Available from: https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html.
  • World Health Organisation. Diabetes key facts Geneva: WHO; 2021 [updated 10 Nov 2021; cited 2022 May 25]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
  • Faurholt‐Jepsen D, Range N, PrayGod G, et al. Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania. Trop Med Int Health. 2013;18(7):822–11.
  • Jiménez-Corona ME, Cruz-Hervert LP, García-García L, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax. 2013;68:214–220.
  • Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9(1):1–15.
  • Root HF. The association of diabetes and tuberculosis. N Engl J Med. 1934;210(3):127–147.
  • Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2· 3 million patients with tuberculosis. Lancet Glob Health. 2019;7:e448–e60.
  • Alebel A, Wondemagegn AT, Tesema C, et al. Prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2019;19(1):1–10.
  • Magee MJ, Salindri AD, Kyaw NTT, et al. Stress hyperglycemia in patients with tuberculosis disease: epidemiology and clinical implications. Curr Diab Rep. 2018;18(9):1–10.
  • Luies L, du Preez I. The echo of pulmonary tuberculosis: mechanisms of clinical symptoms and other disease-induced systemic complications. Clin Microbiol Rev. 2020;33(4). DOI:10.1128/CMR.00036-20
  • Cheng P, Wang L, Gong W. Cellular immunity of patients with tuberculosis combined with diabetes. J Immunol Res. 2022;2022. DOI:10.1155/2022/6837745
  • Krishnappa D, Sharma SK, Singh AD, et al. Impact of tuberculosis on glycaemic status: a neglected association. Indian J Med Res. 2019;149:384.
  • Başoğlu OK, Bacakoğlu F, Cok G, et al. The oral glucose tolerance test in patients with respiratory infections. Monaldi Archives for Chest Disease Archivio Monaldi per le Malattie Del Torace. 1999;54(4):307–310.
  • Tabarsi P, Baghaei P, Marjani M, et al. Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: a cohort study. J Diabetes & Metabolic Disord. 2014;13:1–6.
  • Salindri AD, Wang J-Y, Lin -H-H, et al. Post-tuberculosis incidence of diabetes, myocardial infarction, and stroke: retrospective cohort analysis of patients formerly treated for tuberculosis in Taiwan, 2002–2013. Inter J Infect Dis. 2019;84:127–130.
  • Pearson F, Huangfu P, Pearce M, et al. OP52 exploring the association between tuberculosis and diabetes in a UK primary care dataset. BMJ Publishing Group Ltd; 2016.
  • Yorke E, Atiase Y, Akpalu J, et al. The bidirectional relationship between tuberculosis and diabetes. Tuberc Res Treat. 2017;2017:1702578.
  • Oluboyo PO, Erasmus RT. The significance of glucose intolerance in pulmonary tuberculosis. Tubercle. 1990;71:135–138.
  • Jawad F, Shem A, Memon R, et al. Glucose intolerance in pulmonary tuberculosis. J-Pakistan Med Assoc. 1995;45:237–238.
  • Boillat-Blanco N, Ramaiya KL, Mganga M, et al. Transient hyperglycemia in patients with tuberculosis in Tanzania: implications for diabetes screening algorithms. J Infect Dis. 2016;213(7):1163–1172.
  • Menon S, Francis J, Zdraveska N, et al. The epidemiology of intransient TB-induced hyperglycaemia in previously undiagnosed diabetes mellitus 2 individuals: a protocol for a systematic review and meta-analysis. Syst Rev. 2019;8:1–5.
  • Peters M, Godfrey C, McInerney P, et al. Joanna Briggs Institute reviewer’s manual: Adelaide, Australia: The Joanna Briggs Institute. 2017.
  • Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.
  • Watson JM, Gill ON. HIV infection and tuberculosis. BMJ. 1990;300:63–65.
  • Kumar A, Arora A, Sharma P, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? a meta-analysis. Diabetes Metab Syndr. 2020;14(4):535–545.
  • Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):1–10.
  • Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
  • Purohit S, Gupta P, Agarwal K, et al. Glucose tolerance during rifampicin therapy. Ind J Tub. 1984;31:3.
  • Singh M, Biswas S, Shah A. Impaired glucose tolerance in active pulmonary tuberculosis. Indian J Tuberc. 1984;31(3):118–121.
  • Akinlade K, Rahamon S, Edem V, et al. Glycated haemoglobin levels in patients with multidrug-resistant tuberculosis infection during 6 months of treatment. Afr J Clin Exp Microbiol. 2016;17(3):173–178.
  • Lin Y, Yuan Y, Zhao X, et al. The change in blood glucose levels in tuberculosis patients before and during anti-tuberculosis treatment in China. Glob Health Action. 2017;10:1289737.
  • Moreira J, Castro R, Lamas C, et al. Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil. Inter J Infect Dis. 2018;69:11–19.
  • Diarra B, Tolofoudie M, Sarro Y, et al. Diabetes Mellitus among new tuberculosis patients in Bamako, Mali. J Clin Tuberculosis Other Mycobacterial Dis. 2019;17:100128.
  • Habib SS, Rafiq S, Jamal WZ, et al. Engagement of private healthcare providers for case finding of tuberculosis and diabetes mellitus in Pakistan. BMC Health Serv Res. 2020;20:1–8.
  • Kubjane M, Berkowitz N, Goliath R, et al. Tuberculosis, human immunodeficiency virus, and the association with transient hyperglycemia in periurban South Africa. Clin Infect Dis. 2020;71:1080–1088.
  • Association AD. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes Care. 2019;42((Supplement_1):S13):):.
  • Wang J-Y, Lee L, Hsueh P. Factors changing the manifestation of pulmonary tuberculosis. Int J Tuberc Lung Dis. 2005;9(7):777–783.
  • Huangfu P, Ugarte-Gil C, Golub J, et al. The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. Int J Tuberc Lung Dis. 2019;23(7):783–796.
  • Arriaga MB, Araújo-Pereira M, Barreto-Duarte B, et al. The effect of diabetes and prediabetes on antituberculosis treatment outcomes: a multicenter prospective cohort study. J Infect Dis. 2022;225(4):617–626.
  • Yorke E, Boima V, Dey ID, et al. Transient impact of dysglycemia on sputum conversion among smear-positive tuberculosis patients in a tertiary care facility in Ghana. Clin Med Insights: Circulatory, Respir and Pulm Med. 2021;15:11795484211039830.
  • Faurholt-Jepsen D, Range N, PrayGod G, et al. Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania. PloS one. 2011;6(8):e24215.
  • Ekeke N, Ukwaja KN, Chukwu JN, et al. Screening for diabetes mellitus among tuberculosis patients in Southern Nigeria: a multi-centre implementation study under programme settings. Sci Rep. 2017;7(1):1–8.
  • Munseri PJ, Kimambo H, Pallangyo K. Diabetes mellitus among patients attending TB clinics in Dar es Salaam: a descriptive cross-sectional study. BMC Infect Dis. 2019;19(1):1–8.
  • Oni T, Berkowitz N, Kubjane M, et al. Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control. Eur Respir J. 2017;50(1):1.